VTP‑02

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameVTP‑02
Drug Alias Name89Zr-F8scFv89Zr-F8scFv89Zr-DFO-N-Suc-F8scFvVTP‑02VTP02
ClassificationRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Zirconium > 89Zr +[5] 
Mechanisms of ActionPositron-emission tomography enhancersCoagulation factor VIII modulators
TargetsCoagulation factor VIII
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsLung Neoplasms +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVar2 Pharmaceuticals APS
China Registration ClassN/A

Develop Information

Active CompaniesVar2 Pharmaceuticals APS
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsLung Neoplasms +[14] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A